CLINICAL_TRIALS
ClinicalTrials.gov record update
Plerixafor and G-CSF for the Mobilisation of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) - Safety Study in a General Autologous Transplant Population
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00838357
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:58.202224+00:00
- Published At
- 2015-03-24T00:00:00+00:00
- Record Updated At
- 2015-03-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Lymphoma (Non-Hodgkin\u0027s Lymphoma)", "Hodgkin\u0027s Disease or Multiple Myeloma", "Front Line Mobilization", "Transplantation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-03-24"- protocolSection.identificationModule.nctId
"NCT00838357"- protocolSection.identificationModule.officialTitle
"Plerixafor and G-CSF for the Mobilisation of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Non-Hodgkin\u0027s Lymphoma (NHL), Hodgkin\u0027s Disease (HD) or Multiple Myeloma (MM) - Safety Study in a General Autologous Transplant Population"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.